One‐compound‐multiple‐targets strategy to combat Alzheimer's disease
Author:
- 20 September 2005
- journal article
- review article
- Published by Wiley in FEBS Letters
- Vol. 579 (24) , 5260-5264
Abstract
The present one‐drug‐one‐target paradigm in drug discovery has been considered partially responsible for the more‐funding‐less‐drug predicament in modern pharmaceutical industry. To hit the multiple targets implicated in complex diseases, two strategies, based on multicomponent or single‐ingredient, are conceivable. Although the latter is more difficult to be fulfilled than the former, the recent progress made in the fight against Alzheimer's disease (AD) has brought us the first light of success of the latter strategy. In this review, both synthetic and natural multipotent agents are described, which hit two or more targets implicated in AD, e.g., acetylcholinesterase, monoamine oxidase, amyloid‐β, τ protein, metal ions and reactive oxygen species. Nevertheless, due to the potential risks in safety, absorbability and pharmacokinetics of synthetic multipotent agents, natural counterparts seem more promising in the future development.Keywords
This publication has 38 references indexed in Scilit:
- Theoretical Elucidation of DPPH Radical-Scavenging Activity Difference of Antioxidant XanthonesQSAR & Combinatorial Science, 2005
- β-Lactam antibiotics are multipotent agents to combat neurological diseasesBiochemical and Biophysical Research Communications, 2005
- Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in VivoJournal of Biological Chemistry, 2005
- The “promiscuous drug concept” with applications to Alzheimer's diseaseFEBS Letters, 2005
- Multicomponent therapeutics for networked systemsNature Reviews Drug Discovery, 2005
- Pathways towards and away from Alzheimer's diseaseNature, 2004
- Neurodegenerative diseases and oxidative stressNature Reviews Drug Discovery, 2004
- Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of PathogenesisScience, 2003
- Development of antiinflammatory therapy for Alzheimer's diseaseDrug Development Research, 2002
- Structure-antioxidant activity relationships of flavonoids and phenolic acidsFree Radical Biology and Medicine, 1996